Literature DB >> 6796628

Cost-effectiveness and cost-benefit analyses of vaccines.

J S Willems, C R Sanders.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6796628     DOI: 10.1093/infdis/144.5.486

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  13 in total

Review 1.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

2.  Economic evaluation of vaccination.

Authors:  P Van Damme; P Beutels
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

3.  Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.

Authors:  G M Ginsberg; T H Tulchinsky
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

4.  Global eradication of poliomyelitis: benefit-cost analysis.

Authors:  K J Bart; J Foulds; P Patriarca
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

Review 5.  Immunizations in the elderly.

Authors:  D W Bentley
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

6.  Periodic health examination: comparison of residency programs and national recommendations.

Authors:  K Goldenberg
Journal:  J Gen Intern Med       Date:  1986 Sep-Oct       Impact factor: 5.128

7.  A cost-effectiveness analysis of exercise as a health promotion activity.

Authors:  E I Hatziandreu; J P Koplan; M C Weinstein; C J Caspersen; K E Warner
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

Review 8.  Quality of life. 2. Economic analysis of drug therapies.

Authors:  S V Pham; J R Draugalis
Journal:  Pharm World Sci       Date:  1993-04-23

9.  Assessing the cost-effectiveness of prevention.

Authors:  H D Banta; B R Luce
Journal:  J Community Health       Date:  1983

10.  Chapter 1 The need for chemotherapy and prophylaxis against viral diseases.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.